Question

In: Economics

A new antibiotic has just gained approval from the Food and Drug Administrationso it is now...

A new antibiotic has just gained approval from the Food and Drug Administrationso it is now legal to sell. Demand for the drug is: P = 1000 –Q and supply of the drug is: P = 50 + Q.

a.What is the producer surplus and consumer surplus gained from legalization? Assume zero total surplusexisted before legalization.

b.Policymakers realize there is a negative consumption externality from the drug: as people use the new antibiotic, bacteria become slightly more resistant to the old types of antibiotics. (Note: Just assume this is plausible and true!). In fact, for each unit of drug sold, there is $450 marginal cost to society. What is the magnitude (in $) of the negative externality from the free (unregulated) market solution? [Hint: Only calculate the size of the negative externality, not the deadweight loss.]

c.Propose a policy that would bring the market into efficiency. (Note that this is a short answer question. Be specific enough to show how the policy would bring the market into efficiency. You may use a graph if it would be helpful.)

d.How much would society as a whole be better off (in $) due to your policy from part c, relative to a free (unregulated) market?(This is a quantitative problem.)

Solutions

Expert Solution

Part - (a). After legal approval the demand for Drug is shown by P = 1000 - Q , and supply of Drug is P = 50 + Q.

Equilibrium price and quantity will be determined demand = Supply.

1000 - Q = 50 + Q

Or, 2Q = 950

Or, Q = 475.

Therefore, P = 1000 - 475 = $525.

Equilibrium price P = $525, Equilibrium Quantity Q = 475

Now consumer surplus at P = $525, Q = 475 is -

C.S = 1/2*(base)*(height)

C.S = 0.5*475*(1000 - 525)

C.S = 0.5*475*$475 = $112,812.5 . (Ans)

P.S at P = $525 and Q = 475 is -

P.S = 1/2*(base)*(height)

P.S = 0.5*475*(525 - 50)

P.S = 0.5*475*$475 = $112,812.5.  

Part - (b). If each unit of Drug sold in the market create negative externality of $450 /unit.

Now under unregulated market solution the magnitude of negative externality is $450*Quantity sold = $450*475 = $213,750. (Answer).

Part - (c). Market will be if supplier incorporate the negative externality into their supply. It means if we internalize the external cost of the drug sold per unit. We can do that by imposing per unit tax equal to external cost per unit. We will have new supply function which will show supply (S + tax ) and We can show it by below figure -

Part - (d).

Now under no regulations at free market equilibrium total surplus was C.S + P.S and there was external cost.

Total surplus to society under unregulated condition is

Total surplus = C.S ($112,812.5) + P.S ($112,812.5)

Total surplus = $225,625.

Total loss of society in terms of external cost is = $213,750 at unregulated market solution.

So, Net Gain to society = $225,625 - $213,750 = $11,875.

Now if the external cost is internalised then we will have the new supply function is

P = 50 + Q + tax

Or, P = 50 + Q + 450 , where per unit tax = $450

Or, P = 500 + Q -------- New supply function

Now, we can set the equilibrium Demand = Supply

Demand is P = 1000 - Q , and new supply is P = 500 + Q

1000 - Q = 500 + Q

Or, 2Q = 1000 - 500

Or, Q = 500/2 = 250.

P = 1000 - 250 = $750.

Therefore, new equilibrium price and quantity is P = $750. Q = 250 units.

Now under new equilibrium price = $750 and Q = 250, C.S and P.S are -

C.S = 1/2*(base)*(height)

C.S = 0.5*250*(1000 - 750)

C.S = 0.5*250*250 = $31,250.

P.S at P = $750 and Q = 250 is -

P.S = 1/2*(base)*(height)

P.S = 0.5*250*(750 - 500)

P.S = 0.5*250*$250

P.S = $31,250

Total surplus to society = C.S + P.S

Total Surplus = $31,250 + $31,250 = $62,500.

Tax revenue = Quantity sold multiplied by tax

Tax Revenue = 250*$450 = $112,500

DWL to society due to tax = 1/2*(base)*(height)

DWL to society due to tax = 0.5*(500)*(475 - 250)

DWL to society due to tax = 0.5*500*225 = $56,250.

Total Gain to society = $62,500 + $112,500 - $56,250

Net total gain to society with tax = $118,750.

If we take only C.S + P.S net gain to society is $62,500.


Related Solutions

A drug company applied for the approval of the Food and Drug Administration (FDA) to market...
A drug company applied for the approval of the Food and Drug Administration (FDA) to market a miracle drug that the company believed could cure some cancers. During the period that the application was under consideration the company's stock rose to $65 per share. The president of the company learned that the FDA application was about to be denied. You are a personal friend of the president, and he told you that he believed that the stock will start trading...
XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The company has never...
XYZ Pharmaceutical, Inc. just got FDA approval for their new drug, Viagrina. The company has never paid a dividend, but they expect to pay one for the first time by the end of the year. The expected dividend is $3.00 per share and the company expects that dividend to increase at a rate of 20% for five years. After that, XYZ expects to see its dividend growth limited by the growth rate the US economy, which on average is 4.5%...
The Food and Drug Administration (FDA) is asked to approve a new drug. The new drug...
The Food and Drug Administration (FDA) is asked to approve a new drug. The new drug should contain less than 25mg of the active ingredient “toxin”, which is assumed to have dangerous side effects. The FDA would like to restrict the error of “approving the drug despite its too high content of toxin” to a maximum risk of 5% (α ≤ 0.05). Let Xi : “ The content of toxin in the i-th pill [in mg].” ∼ N(µ, σ2 )...
1. Describe the significance of phase 4 in the process of new drug approval. What is...
1. Describe the significance of phase 4 in the process of new drug approval. What is a goal of postmarketing surveillance (PMS) in a new drug approval process?
1 . The Food and Drug Administration has decided if a particular food product has 8...
1 . The Food and Drug Administration has decided if a particular food product has 8 grams or more of impurities it should be banned. A random sample of 36 cans of Tomato soup produced by Classic Food, Inc. showed 7.4 grams of impurities with a standard deviation of 3 grams. Test the hypothesis at the 1% level of significance. Please show the process of getting the answer 2. A production process is designed to fill cans with exactly 32...
An antibiotic, which is also used as an anticancer drug, was isolated from Streptomycetes bacteria. Its...
An antibiotic, which is also used as an anticancer drug, was isolated from Streptomycetes bacteria. Its elemental analysis gives the following composition (by weight): %C 57.89 %H 6.87 %N 13.97 %O 21.27 The formula weight is found (in a seperate experiment) to be NEAR 1300g/mole. Determine the MOLECULAR FORMULA of the antibiotic. show ALL work.
An octapeptide was isolated from a fungus for use as a new antibiotic. The composition of...
An octapeptide was isolated from a fungus for use as a new antibiotic. The composition of the peptide was 2 Gly, Lys, Met, Pro, Arg, Trp, Tyr. Edman degradation of the intact peptide yields FDNB- glycine. The peptide was then treated with carboxypeptidase A, B and C, only carboxypeptidase C had any effect cleaving off Pro. The peptide was then treated with trypsin (cleaves at Arg and Lys), which gave two tripeptides and a dipeptide.   The compositions of the tripeptides...
1. The year is 1999 and the Ethical Pharmaceutics Company has just received FDA approval for...
1. The year is 1999 and the Ethical Pharmaceutics Company has just received FDA approval for high risk angioplasties and is bringing AngioMin to the market early January 2000 at the price of $200. The cost of manufacturing a single dose of AngioMin is $40. The key benefit of AngioMin is reduced side effects, complications, and risk of death following angioplasty. These benefits are most pronounced in the very high risk patients. Ethical Pharmaceutics Company’s marketing department decided to focus...
4.Your firm spent $100 million developing a new drug. It has now been approved for sale,...
4.Your firm spent $100 million developing a new drug. It has now been approved for sale, and each pill costs $1 to manufacture. Your market research suggests that the price elasticity of demand in the general public is −1.1. What price do you charge the public? What would happen to profits if you charged twice as much? What role does the $100 million in development costs play in your pricing decision? 
 The Medicaid agency has made a take-it-or-leave-it offer of...
The Food and Drug Administration uses a premanufacturing screening program for determining the marketability of new...
The Food and Drug Administration uses a premanufacturing screening program for determining the marketability of new pharmaceutical products, whereas the U.S. Consumer Product Safety Commission relies on recall actions for products found to be defective, such as electric coffee-makers that short out. Can you think of any rationale other than historical accident for the difference in regulatory approaches between the two agencies? (Chp. 22)
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT